Paper Details

  1. Home
  2. Paper Details

[Controversy on platelet-inhibiting drugs].

Author: OelzO

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Aspirin is the only established platelet-inhibiting drug, with a recommended dose of 100-300 mg daily. It reduces mortality and infarction rates in patients who have had myocardial infarction by 0-30%. The efficacy of additional dipyridamol or sulfinpyrazone is not proven.
Paper Details　
Original Abstract of the Article :
The only well established, clinically useful platelet inhibiting drug is aspirin, though the optimal dose is unknown. Experimental findings, the virtual absence of side effects and, so far, four clinical studies favour a dose of 100-300 mg per day. The majority of clinical studies, however, and part...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3892659

データ提供：米国国立医学図書館（NLM）

Platelet-Inhibiting Drugs: Navigating the Complexities of Cardiovascular Health

Platelet-inhibiting drugs play a crucial role in preventing blood clots and reducing the risk of cardiovascular events. This review article explores the use of aspirin, a commonly prescribed platelet inhibitor, in various cardiovascular conditions. The author, like a seasoned desert guide, navigates the intricate landscape of platelet inhibition, outlining the evidence for aspirin's effectiveness and the ongoing debate about its optimal dose.

Aspirin: A Powerful Tool in the Fight Against Cardiovascular Disease

The review highlights the established benefits of aspirin in reducing mortality and infarction rates in patients who have already experienced myocardial infarction. However, the optimal dose of aspirin remains a subject of ongoing debate. The author underscores the importance of carefully considering the potential benefits and risks of aspirin treatment based on individual patient needs and specific cardiovascular conditions.

Understanding the Nuances of Platelet Inhibition

This review emphasizes the importance of understanding the complexities of platelet inhibition and the need for personalized treatment strategies. It highlights the importance of ongoing research to optimize the use of platelet-inhibiting drugs, ensuring that patients receive the most effective and safe treatment possible. This research is like a desert map, guiding us through the complex terrain of cardiovascular health.

Dr. Camel's Conclusion

This review, like a sand dune shifting in the desert, reminds us of the ever-evolving landscape of cardiovascular medicine. It emphasizes the importance of remaining informed about the latest evidence and adapting our approaches to ensure optimal outcomes for patients.

Date :
  1. Date Completed 1985-08-12
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

3892659

DOI: Digital Object Identifier

3892659

Related Literature

Article Analysis
・Side Effects of sulfinpyrazone
SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.